Axtria Blog

Axtria makes the NJBIZ Fast 50 list for the fourth consecutive year

We are proud to share that Axtria has made NJBIZ’s Fast 50 list of the fastest growing companies in New Jersey. It is our fourth year on the list, and we are ranked 11th for 2017.

Read More

Axtria Ranks in Deloitte’s Technology Fast 500™, yet Again!

At Axtria we are very excited to have been ranked number 270 on Deloitte’s Technology Fast 500™ list for 2017. This recognition marks Axtria’s third consecutive year amongst Deloitte’s fastest growing companies, and we are honored and extremely proud of this achievement. 

Read More

Axtria ranks in CIOReview’s 20 Most Promising Pharma and Life Sciences Tech Solution Providers 2017 list

Axtria is extremely proud to rank in the CIOReview Tech Solution Providers list for 2017, which is an annual listing of 20 companies that are at the forefront of providing Pharma and Life Science solutions and impacting the market.

Read More

Axtria Ranks in Crain’s Fast 50 New York Companies

Axtria is extremely proud to rank in Crain’s New York Business Fast 50 List for 2017. The ranking highlights the city's 50 fastest-growing companies with its annual Fast 50 feature. It celebrates the success of innovative companies and recognizes their business strategies and accelerated revenue growth.

Read More

Insightful HEOR analysis for the cardiovascular community

Some of the most rewarding work we are involved in at Axtria right now is in the Health Economics and Outcomes Research (HEOR) space, where we are partnering with our clients to help demonstrate the value of their medications and get them to the patients who need them. Challenges in the healthcare space—including rising costs, an aging population, advanced technology, and increased patient awareness of medical options—have resulted in an increase in evaluating medications from an HEOR perspective. Through our modelling and analytical work, we work with clients and key opinion leaders (KOLs) to identify which patients would benefit from various treatment options and the impact those treatments could have on patient health.

Read More

The Commercial Excellence Survey Report awaits you at Veeva Summit 2017

The final countdown to the Veeva Commercial Summit has begun and we are only a few days away from one of the most exciting events on the pharma calendar. This year, besides our interesting lineup of activities at our booth we have a very compelling Commercial Excellence Survey report to share with you. We recently conducted this survey to understand the current state of commercial excellence across the industry.

Read More

Drive Sales Performance with Smarter Decisions at Veeva 2017

Axtria is excited to be back as a gold sponsor at the Veeva Summit 2017. This is always one of our favorite events of the year, with so many industry professionals and Veeva experts together in one place. We hear there will be more than 1,200 of us this year in Philadelphia, which just highlights the significance of this event and the themes covered.

Read More

Last But Not Least - Data Strategy & Governance at PMSA 2017!

We always save the best until last, and PMSA 2017 is no exception. On Wednesday 26th April, we will conclude the conference with an insightful presentation from Asheesh Sharma and Vineet Rathi on Data Strategy and Governance: A Strategic Enabler of Next Generation Analytics and Insight Driven Commercial Excellence.

Read More

Don't miss our Presentation on the impact of social media data on sales forecasting!

Following up on our busy agenda for PMSA 2017, on Tuesday April 25th we have Ashish Sharma and Cheng Wang answering the question “Can Social Media Data Improve Sales Forecasting?”.

Read More

Newsletter Sign-Up

FOLLOW

Recent Posts